[Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].

@article{Takeyama1983VaccineTO,
  title={[Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].},
  author={Hideo Takeyama and Tomoo Watanabe and Philip O. Livingston},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={1983},
  volume={10 7},
  pages={1624-33}
}
Serological studies were performed on melanoma patients for the response of allogeneic melanoma cell vaccine derived from the melanoma cell line SK-MEL-13 (Patient AH) expressing a shared tumor antigen (AH antigen system). AH antigen system was initially identified by autologous typing system and is known to be immunogenic in man. Twenty melanoma patients were treated with multiple intradermal injections of AH vaccine. Their sera were then tested by immunoadherence (IA) and Protein A (PA… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…